Intestinal Research

Tumor
Prevalence and risk factors of colorectal cancer in Asia: Martin CS Wong, Hanyue Ding, Jingxuan Wang, Paul SF Chan, Junjie Huang; Intest Res. 2019;17(3):317-329. Published online May 20, 2019; DOI: https://doi.org/10.5217/ir.2019.00021
Cited By 55; Full text PubReader ePub Crossref - TDM PDF

IBD
Epidemiological trend in inflammatory bowel disease in Taiwan from 2001 to 2015: a nationwide populationbased study: Hsu-Heng Yen, Meng-Tzu Weng, Chien-Chih Tung, Yu-Ting Wang, Yuan Ting Chang, Chin-Hao Chang, Ming-Jium Shieh, Jau-Min Wong, Shu-Chen Wei; Intest Res. 2019;17(1):54-62. Published online November 20, 2018; DOI: https://doi.org/10.5217/ir.2018.00096
Cited By 42; Full text PubReader ePub Crossref - TDM PDF

Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn’s disease in Asia: Choon Jin Ooi, Ida Hilmi, Rupa Banerjee, Sai Wei Chuah, Siew Chien Ng, Shu Chen Wei, Govind K Makharia, Pises Pisespongsa, Min Hu Chen, Zhi Hua Ran, Byong Duk Ye, Dong Il Park, Khoon Lin Ling, David Ong, Vineet Ahuja, Khean Lee Goh, Jose Sollano, Wee Chian Lim, Wai Keung Leung, Raja Affendi Raja Ali, Deng Chyang Wu, Evan Ong, Nazri Mustaffa, Julajak Limsrivilai, Tadakazu Hisamatsu, Suk Kyun Yang, Qin Ouyang, Richard Geary, Janaka H De Silva, Rungsun Rerknimitr, Marcellus Simadibrata, Murdani Abdullah, Rupert WL Leong, the Asia Pacific Association of Gastroenterology (APAGE) Working Group on Inflammatory Bowel Disease and Asian Organization for Crohn’s and Colitis; Intest Res. 2019;17(3):285-310. Published online May 31, 2019; DOI: https://doi.org/10.5217/ir.2019.00026
Cited By 37; Full text PubReader ePub Crossref - TDM PDF

Efficacy of fecal microbiota therapy in steroid dependent ulcerative colitis: a real world intention-to-treat analysis: Ajit Sood, Ramit Mahajan, Garima Juyal, Vandana Midha, Charanpreet Singh Grewal, Varun Mehta, Arshdeep Singh, Mohan C Joshi, Vikram Narang, Kirandeep Kaur, Hasrat Sidhu; Intest Res. 2019;17(1):78-86. Published online November 20, 2018; DOI: https://doi.org/10.5217/ir.2018.00089
Cited By 25; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Inflammatory bowel diseases
Recent updates on the basic mechanisms and pathogenesis of inflammatory bowel diseases in experimental animal models: Emiko Mizoguchi, Daren Low, Yui Ezaki, Toshiyuki Okada; Intest Res. 2020;18(2):151-167. Published online April 20, 2020; DOI: https://doi.org/10.5217/ir.2019.09154
Cited By 21; Full text PubReader ePub Crossref - TDM PDF

Novel biomarkers for the diagnosis and prognosis of colorectal cancer: Hyung-Hoon Oh, Young-Eun Joo; Intest Res. 2020;18(2):168-183. Published online November 30, 2019; DOI: https://doi.org/10.5217/ir.2019.00080
Cited By 17; Full text PubReader ePub Crossref - TDM PDF

IBD
Current new challenges in the management of ulcerative colitis: Tomohiro Fukuda, Makoto Naganuma, Takanori Kanai; Intest Res. 2019;17(1):36-44. Published online January 25, 2019; DOI: https://doi.org/10.5217/ir.2018.00126
Cited By 17; Full text PubReader ePub Crossref - TDM PDF

Functional bowel disorders
Evaluation of symptoms and symptom combinations in histamine intolerance: Wolfgang J. Schnedl, Sonja Lackner, Dietmar Enko, Michael Schenk, Sandra J. Holasek, Harald Mangge; Intest Res. 2019;17(3):427-433. Published online March 7, 2019; DOI: https://doi.org/10.5217/ir.2018.00152
Cited By 16; Full text PubReader ePub Crossref - TDM PDF

Tumor
Nutritional issues in patients with cancer: Duk Hwan Kim; Intest Res. 2019;17(4):455-462. Published online October 14, 2019; DOI: https://doi.org/10.5217/ir.2019.00076
Cited By 14; Full text PubReader ePub Crossref - TDM PDF

Inflammatory bowel diseases
Ustekinumab is effective in biological refractory Crohn’s disease patients–regardless of approval study selection criteria: Sadik Saman, Martin Goetz, Judith Wendler, Nisar P. Malek, Jan Wehkamp, Thomas Klag; Intest Res. 2019;17(3):340-348. Published online May 31, 2019; DOI: https://doi.org/10.5217/ir.2019.00012
Cited By 12; Full text PubReader ePub Crossref - TDM PDF

The prevalence of sarcopenia and its effect on prognosis in patients with Crohn’s disease: Chan Hyung Lee, Hyuk Yoon, Dong Jun Oh, Jae Min Lee, Yoon Jin Choi, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee, Joo Sung Kim; Intest Res. 2020;18(1):79-84. Published online January 30, 2020; DOI: https://doi.org/10.5217/ir.2019.00107
Cited By 11; Full text PubReader ePub Crossref - TDM PDF

IBD
Does fecal calprotectin equally and accurately measure disease activity in small bowel and large bowel Crohn’s disease?: a systematic review: Ebby George Simon, Richard Wardle, Aye Aye Thi, Jeanette Eldridge, Sunil Samuel, Gordon William Moran; Intest Res. 2019;17(2):160-170. Published online February 7, 2019; DOI: https://doi.org/10.5217/ir.2018.00114
Cited By 11; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Inflammatory bowel diseases
Fibrostenotic strictures in Crohn’s disease: Jun Hwan Yoo, Stefan Holubar, Florian Rieder; Intest Res. 2020;18(4):379-401. Published online April 10, 2020; DOI: https://doi.org/10.5217/ir.2019.09148
Cited By 10; Full text PubReader ePub Crossref - TDM PDF

IBD
Influence of anti-tumor necrosis factor-alpha therapy to pregnant inflammatory bowel disease women and their children’s immunity: Ko Eun Lee, Sung-Ae Jung, Sang Hyoung Park, Chang Mo Moon, So Yeon Shim, Eun Soo Kim, Su Jin Cho, Seong-Eun Kim, Kwang Bum Cho, Suk-Kyun Yang; Intest Res. 2019;17(2):237-243. Published online February 8, 2019; DOI: https://doi.org/10.5217/ir.2018.00071
Cited By 10; Full text PubReader ePub Crossref - TDM PDF

Inflammatory bowel diseases
Pathogenesis and clinical perspectives of extraintestinal manifestations in inflammatory bowel diseases: Jung Min Kim, Jae Hee Cheon; Intest Res. 2020;18(3):249-264. Published online April 18, 2020; DOI: https://doi.org/10.5217/ir.2019.00128
Cited By 9; Full text PubReader ePub Crossref - TDM PDF

Most cited